Scott Horvitz is a seasoned entrepreneur and financial executive, boasting over 25 years of invaluable expertise in managing life sciences and emerging growth companies. He has a proven track record of transitioning three organizations from venture-backed start-ups to publicly traded companies, raising over $250 million in the process. His areas of expertise include fund raising, mergers and acquisitions, contract negotiation, budgeting, SEC reporting, corporate governance, investor relations, business development, facilities management, and human resources. Mr. Horvitz is the President and CEO of Opertech Bio, Inc., a company he co-founded in 2011. Prior to starting Opertech Bio, Mr. Horvitz was the CFO of Redpoint Bio Corporation. He also co-founded 3-Dimensional Pharmaceuticals, Inc., where he worked from its inception in 1993 until its acquisition by Johnson & Johnson in 2003. At 3-Dimensional Pharmaceuticals, he served the organization most recently as its Chief Financial Officer and Corporate Secretary and Treasurer. Mr. Horvitz served on the Board of Directors of Protez Pharmaceuticals, Inc. and was the Chairman of its Audit Committee from 2004 until its acquisition by Novartis in 2008. Additionally, he was Director of Finance at Magainin Pharmaceuticals, Inc. and a Senior Audit Manager at Eisner LLP.

In June 2007, Mr. Horvitz was the recipient of the New Jersey Technology Council CFO of the Year Award. He holds a Bachelor of Science in Accounting from the University at Albany and is a Certified Public Accountant.